The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Gene Variants Associated With Deep Vein Thrombosis
Abstract
CONTEXT: The genetic causes of deep vein thrombosis (DVT) are not fully understood. OBJECTIVE: To identify single-nucleotide polymorphisms (SNPs) associated with DVT. DESIGN, SETTING, AND PATIENTS: We used 3 case-control studies of first DVT. A total of 19 682 gene-centric SNPs were genotyped in 443 cases and 453 controls from the Leiden Thrombophilia Study (LETS, 1988-1992). Twelve hundred six SNPs associated with DVT were reinvestigated in the Multiple Environmental and Genetic Assessment of Risk Factors for Venous Thrombosis study (MEGA-1, 1999-2004) in a subset of 1398 cases and 1757 controls. Nine SNPs associated with DVT in both LETS and MEGA-1 were investigated a third time in 1314 cases and 2877 controls from MEGA-2, a second subset of MEGA. Additional SNPs close to one SNP in CYP4V2 were genotyped in LETS and MEGA-1. MAIN OUTCOME MEASURE: Odds ratios (ORs) for DVT were estimated by logistic regression. False discovery rates served to investigate the effect of multiple hypothesis testing. RESULTS: Of 9 SNPs genotyped in MEGA-2, 3 were strongly associated with DVT (P < .05; false discovery rate < or =.10): rs13146272 in CYP4V2 (risk allele frequency, 0.64), rs2227589 in SERPINC1 (risk allele frequency, 0.10), and rs1613662 in GP6 (risk allele frequency, 0.84). The OR for DVT per risk allele was 1.24 (95% confidence interval [95%CI], 1.11-1.37) for rs13146272, 1.29 (95% CI, 1.10-1.49) for rs2227589, and 1.15 (95% CI, 1.01-1.30) for rs1613662. In the region of CYP4V2, we identified 4 additional SNPs (in CYP4V2, KLKB1, and F11) that were also associated with both DVT (highest OR per risk allele, 1.39; 95% CI, 1.11-1.74) and coagulation factor XI level (highest increase per risk allele, 8%; 95% CI, 5%-11%). CONCLUSIONS: We identified SNPs in several genes that were associated with DVT. We also found SNPs in the region around the SNP in CYP4V2 (rs13146272) that were associated with both DVT and factor XI levels. These results show that common genetic variation plays an important role in determining thrombotic risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Poort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
Weir, B. S. (1997) · Biometrics · doi:10.2307/2533134 · Cited by 2,263
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
Blom, J. W. (2005) · JAMA · doi:10.1001/jama.293.6.715 · Cited by 1,949
Venous thrombosis: a multicausal disease
Rosendaal, F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10266-0 · Cited by 1,576
Incidence and mortality of venous thrombosis: a population‐based study
NÆSS, I. A., CHRISTIANSEN, S. C., ROMUNDSTAD, P., CANNEGIETER, S. C., ROSENDAAL, F. R., & HAMMERSTRØM, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02450.x · Cited by 1,413
Koster, T., Vandenbroucke, J., Rosendaal, F., de Ronde, H., Briët, E., & Bertina, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,239
High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis
Meijers, J. C. M., Tekelenburg, W. L. H., Bouma, B. N., Bertina, R. M., & Rosendaal, F. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421004 · Cited by 700
The Epidemiology of Venous Thromboembolism in the Community
Mohr, D., Petterson, T., Lohse, C., O’Fallon, W. M., Melton, L. J., Heit, J., & Silverstein, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616243 · Cited by 571
Absence of Thrombosis in Subjects with Heterozygous Protein C Deficiency
Miletich, J., Sherman, L., & Broze, G. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710153171604 · Cited by 524
A Crucial Role of Glycoprotein VI for Platelet Recruitment to the Injured Arterial Wall In Vivo
Massberg, S., Gawaz, M., Grüner, S., Schulte, V., Konrad, I., Zohlnhöfer, D., Heinzmann, U., & Nieswandt, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020945 · Cited by 516
High-Throughput SNP Allele-Frequency Determination in Pooled DNA Samples by Kinetic PCR
Germer, S., Holland, M. J., & Higuchi, R. (2000) · Genome Research · doi:10.1101/gr.10.2.258 · Cited by 419
High levels of factor IX increase the risk of venous thrombosis
Vlieg, A. V. H., van der Linden, I. K., Bertina, R. M., & Rosendaal, F. R. (2000) · Blood · doi:10.1182/blood.v95.12.3678 · Cited by 404
Souto, J. C., Almasy, L., Borrell, M., Blanco-Vaca, F., Mateo, J., Soria, J. M., Coll, I., Felices, R., Stone, W., Fontcuberta, J., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316903 · Cited by 338
Bietti Crystalline Corneoretinal Dystrophy Is Caused by Mutations in the Novel Gene CYP4V2
Li, A., Jiao, X., Munier, F. L., Schorderet, D. F., Yao, W., Iwata, F., Hayakawa, M., Kanai, A., Shy Chen, M., Alan Lewis, R., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/383228 · Cited by 287
Association of Genetic Variations With Nonfatal Venous Thrombosis in Postmenopausal Women
Smith, N. L., Hindorff, L. A., Heckbert, S. R., Lemaitre, R. N., Marciante, K. D., Rice, K., Lumley, T., Bis, J. C., Wiggins, K. L., Rosendaal, F. R., et al. (2007) · JAMA · doi:10.1001/jama.297.5.489 · Cited by 207
Association of Gene Variants With Incident Myocardial Infarction in the Cardiovascular Health Study
Shiffman, D., O’Meara, E. S., Bare, L. A., Rowland, C. M., Louie, J. Z., Arellano, A. R., Lumley, T., Rice, K., Iakoubova, O., Luke, M. M., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.153981 · Cited by 167
Mutation in blood coagulation factor V associated with resistance to activated protein C
Freedman, J. J., & Dzik, S. (1995) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(05)80032-x · Cited by 165
Identification of Four Gene Variants Associated with Myocardial Infarction
Shiffman, D., Ellis, S. G., Rowland, C. M., Malloy, M. J., Luke, M. M., Iakoubova, O. A., Pullinger, C. R., Cassano, J., Aouizerat, B. E., Fenwick, R. G., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/491674 · Cited by 160
Major Genetic Susceptibility for Venous Thromboembolism in Men: A Study of Danish Twins
Larsen, T. B., Sørensen, H. T., Skytthe, A., Johnsen, S. P., Vaupel, J. W., & Christensen, K. (2003) · Epidemiology · doi:10.1097/01.ede.0000060457.51194.bc · Cited by 136
Minor Injuries as a Risk Factor for Venous Thrombosis
van Stralen, K. J. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.5 · Cited by 126
Gene Variants of VAMP8 and HNRPUL1 Are Associated With Early-Onset Myocardial Infarction
Shiffman, D., Rowland, C. M., Louie, J. Z., Luke, M. M., Bare, L. A., Bolonick, J. I., Young, B. A., Catanese, J. J., Stiggins, C. F., Pullinger, C. R., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000226543.77214.e4 · Cited by 91
The metabolism of fatty acids in human Bietti crystalline dystrophy.
Lee, J., Jiao, X., Hejtmancik, J. F., Kaiser‐Kupfer, M. I., Gahl, W. A., Markello, T. C., Guo, J., & Chader, G. J. (2001) · PubMed · Cited by 90
Platelet activation in acute pulmonary embolism
Chung, T., CONNOR, D. E., Joseph, J. E., et al. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02461.x · Cited by 86
Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX.
McGraw, R. A., Davis, L. M., Noyes, C. M., et al. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.9.2847 · Cited by 81
Gallimore, M. J., Harris, S. L., Jones, D. W., & Winter, M. R. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.05.005 · Cited by 46
Iakoubova, O. A., Tong, C. H., Chokkalingam, A. P., Rowland, C. M., Kirchgessner, T. G., Louie, J. Z., Ploughman, L., Sabatine, M. S., Campos, H., Catanese, J. J., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000247248.76409.8b · Cited by 33
Cited by
New Fundamentals in Hemostasis
Versteeg, H. H., Heemskerk, J. W. M., Levi, M., & Reitsma, P. H. (2013) · Physiological Reviews · doi:10.1152/physrev.00016.2011 · Cited by 1,126
Kujovich, J. L. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3181faa0f2 · Cited by 419
Propagation of Human Spermatogonial Stem Cells In Vitro
Sadri-Ardekani, H. (2009) · JAMA · doi:10.1001/jama.2009.1689 · Cited by 375
Wolberg, A. S., Rosendaal, F. R., Weitz, J. I., Jaffer, I. H., Agnelli, G., Baglin, T., & Mackman, N. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.6 · Cited by 369
Trégouët, D.-A., Heath, S., Saut, N., Biron-Andreani, C., Schved, J.-F., Pernod, G., Galan, P., Drouet, L., Zelenika, D., Juhan-Vague, I., et al. (2009) · Blood · doi:10.1182/blood-2008-11-190389 · Cited by 318
Metadata
- Authors
- Bezemer, I. D.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-03-19
- Volume
- 299
- Issue
- 11
- Pages
- 1306
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2162088713
- Cited by
- 304
- References
- 30
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.